APOLD1

Chr 12AD

apolipoprotein L domain containing 1

Also known as: BDVAS, VERGE

APOLD1 encodes a protein that modulates endothelial barrier permeability and is required for proper organization of endothelial cell-cell junctions and cytoskeleton. Mutations cause a vascular-type bleeding disorder with autosomal dominant inheritance. The gene shows low constraint to loss-of-function variation (pLI 0.0001, LOEUF 1.74).

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

?Bleeding disorder, vascular-typeMIM #620715
AD
0
Active trials
4
Pubs (1 yr)
45
P/LP submissions
0%
P/LP missense
1.74
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryAPOLD1
🧬
Gene-Disease Validity (ClinGen)
inherited blood coagulation disorder · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
45 unique Pathogenic / Likely Pathogenic· 61 VUS of 114 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.74LOEUF
pLI 0.000
Z-score 0.10
OE 0.96 (0.521.74)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.45Z-score
OE missense 0.89 (0.771.04)
120 obs / 134.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.96 (0.521.74)
00.351.4
Missense OE0.89 (0.771.04)
00.61.4
Synonymous OE0.81
01.21.6
LoF obs/exp: 6 / 6.3Missense obs/exp: 120 / 134.7Syn Z: 1.18
DN
0.7229th %ile
GOF
0.77top 25%
LOF
0.3065th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

114 submitted variants in ClinVar

Classification Summary

Pathogenic43
Likely Pathogenic2
VUS61
Likely Benign1
43
Pathogenic
2
Likely Pathogenic
61
VUS
1
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
43
0
43
Likely Pathogenic
0
0
2
0
2
VUS
0
56
5
0
61
Likely Benign
0
0
1
0
1
Benign
0
0
0
0
0
Total056510107

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

APOLD1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC